| Richard B Stafford, MD | |
|
3301 N Ballard Rd, Suite C, Appleton, WI 54911-8988 | |
| (920) 202-3954 | |
| (920) 202-3964 |
| Full Name | Richard B Stafford |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 3301 N Ballard Rd, Appleton, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235293317 | NPI | - | NPPES |
| 31233300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 14405 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard B Stafford, MD 3301 N Ballard Rd, Suite C, Appleton, WI 54911-8988 Ph: (920) 202-3954 | Richard B Stafford, MD 3301 N Ballard Rd, Suite C, Appleton, WI 54911-8988 Ph: (920) 202-3954 |
News Archive
Reviewing published reports, Ferkol and Margaret Leigh, M.D., professor of pediatrics at the University of North Carolina at Chapel Hill (UNC), found that neonatal respiratory distress was a common clinical symptom of PCD, a chronic airway disease that affects about 1 in 15,000 children.
SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that ITOCHU CHEMICAL FRONTIER Corporation (ICF, Tokyo Japan), a member of ITOCHU Corporation, one of the three leading sogo shosha (general trading companies) in Japan, has made a strategic investment in SCILEX.
A distinguished panel of medical experts, state and federal health officials, and congenital heart disease parent advocates published recommended updates to the current American Academy of Pediatrics' protocol for detecting critical congenital heart disease (CCHD) in newborn babies using pulse oximetry.
A new drug has shown promising results against breast and prostate cancer cells and tumours that are resistant to conventional hormone-based treatments, according to research published in the British Journal of Cancer.
Compandia has announced a name change to CompanDX. The company is a biomarker discovery company providing services to the Pharma and Biotech sectors but increasingly, as a result of in-house R&D, is identifying biomarkers that may lead to new diagnostic services and products of its own. Andy Sutton CEO of CompanDX explained "we have grown the service side of the business over the last 9 months and are delivering biomarker discovery services to large pharma, small biotech and diagnostic companies.
› Verified 5 days ago
Dr. Mark T. Rovick, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 444 N Westhill Blvd, Appleton, WI 54914 Phone: 920-750-7000 Fax: 920-364-2451 | |
Dr. Brian Michael Demuri, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 10 Tri Park Way, Appleton, WI 54914 Phone: 920-831-7908 | |
Dr. Padma Reddi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 10 Tri Parkway, Appleton, WI 54914 Phone: 920-831-7908 | |
David L Sovine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1531 S Madison St, Appleton, WI 54915 Phone: 920-730-4411 | |
Dr. Herbert Martin Allen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3301 N Ballard Rd, Suite C, Appleton, WI 54911 Phone: 920-202-3954 Fax: 920-202-3964 | |
Michael J Panzer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1531 S Madison Street, #550, Appleton, WI 54915 Phone: 920-738-2700 Fax: 920-738-8051 |